What are the top competitors of Arzneiwerk AG VIDA in Healthcare sector?

The top competitors of Arzneiwerk AG VIDA in the Healthcare sector are: Henry Schein, Inc. (HS2.DE), Medios AG (ILM1.DE).

Which has better valuations & earnings, Arzneiwerk AG VIDA or its competitors?

Arzneiwerk AG VIDA has a market cap of 1.8M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: Arzneiwerk AG VIDA or its competitors?

Arzneiwerk AG VIDA has an EPS of €-0.11, while HS2.DE has an EPS of €3.23. So, Arzneiwerk AG VIDA is more profitable compared to HS2.DE.

What is Arzneiwerk AG VIDA stock volatility and risk in terms of investment?

Arzneiwerk AG VIDA has daily volatility of 0.66% as compared to its competitor HS2.DE which is 0.03%. Arzneiwerk AG VIDA is more volatile as compared to competitors and has high risk.

Is Arzneiwerk AG VIDA stock profitable?

Arzneiwerk AG VIDA has a Return on Equity (ROE) of 0.00%. So, Arzneiwerk AG VIDA is more profitable.

What is Arzneiwerk AG VIDA stock’s 52 weeks high and low?

Arzneiwerk AG VIDA stock has a 52-week high of (€0.69) and a low of (€0.0005).

What was the average volume of Arzneiwerk AG VIDA stock?

The average volume of Arzneiwerk AG VIDA is (257) in terms of investment.

Arzneiwerk AG VIDA (TLIK.F) Competitors

Arzneiwerk AG VIDA (TLIK.F) Stock Competitors & Peer Comparison

See (TLIK.F) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Distribution Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
TLIK.F	€0.30	+0.00%	1.8M	-2.76	-€0.11	N/A
HS2.DE	€74.06	+0.11%	9.4B	22.93	€3.23	N/A
ILM1.DE	€12.84	+4.22%	317.2M	14.76	€0.87	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

TLIK.F vs HS2.DE Comparison May 2026

TLIK.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TLIK.F stands at 1.8M. In comparison, HS2.DE has a market cap of 9.4B. Regarding current trading prices, TLIK.F is priced at €0.30, while HS2.DE trades at €74.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TLIK.F currently has a P/E ratio of -2.76, whereas HS2.DE's P/E ratio is 22.93. In terms of profitability, TLIK.F's ROE is +0.00%, compared to HS2.DE's ROE of +0.12%. Regarding short-term risk, TLIK.F is more volatile compared to HS2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for TLIK.F.Check HS2.DE's competition here

Arzneiwerk AG VIDA